Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Dec 9, 2013
Clinical News

Treanda endamustine regulatory update

BioCentury | Nov 18, 2013
Clinical News

Treakisym bendamustine: Phase II discontinued

BioCentury | Sep 23, 2013
Clinical News

Treanda regulatory update

BioCentury | May 20, 2013
Clinical News

Treanda: Phase II started

BioCentury | Mar 25, 2013
Clinical News

Treanda bendamustine regulatory update

BioCentury | Jan 28, 2013
Clinical News

Bendamustine: Phase II start

BioCentury | Sep 3, 2012
Clinical News

Treanda regulatory update

BioCentury | Mar 5, 2012
Company News

InnoPharmax sales and marketing update

Items per page:
1 - 9 of 9